Amber Walsh is the former Chairwoman of the firm's Healthcare Department, one of the largest healthcare practices in the United States. She sits on the firm’s Executive Committee and is Chairwoman of the firm’s Lateral Partner Integration Committee, and is a recognized leader in promoting the advancement of women in the private equity sector.
She founded and leads McGuireWoods’ Women in Private Equity & Finance Initiative and sits on the board of The Leverage Network.
Focusing her practice on corporate healthcare transactional work and regulatory matters, she represents healthcare providers such as hospitals, health systems, dialysis facilities, multi- and single-specialty medical practices, specialty hospitals, ambulatory surgery centers, and a variety of healthcare industry entrepreneurs, in sales and acquisitions, joint ventures, general corporate matters, contracting, securities, and regulatory matters.
Her work includes negotiating and drafting transaction documents and counseling clients with regard to the legal aspects of day-to-day operations, including general corporate matters; anti-kickback and Stark issues; self-referral, corporate practice of medicine and fee-splitting prohibitions; HIPAA, certificate of need and licensure requirements; and state and federal securities matters. In 2017, Amber was named to Mergers & Acquisitions magazine’s list of “The Most Influential Women in Mid-Market M&A.”
As one of the principal drivers behind McGuireWoods’ healthcare private equity initiatives, Amber co-chairs the firm’s annual Healthcare and Life Sciences Private Equity and Finance Conference, one of the largest private equity events in the U.S. healthcare market, which facilitates deals by connecting investors with surgery centers, dialysis facilities, physician practices and other industry players.
A recognized thought-leader in the healthcare/M&A and private equity arenas, Amber co-authors a regular Law360 column covering middle market healthcare and life sciences deals, co-writes McGuireWoods’ The Healthcare Investor blog, and is the lead author on a series which spotlights women private equity leaders.
Board of Directors, TaTa Sisterhood Foundation
Member, St. Louis Health Lawyers Association
Board Member, The Leverage Network
Investor, Portfolia Funds
Selected for inclusion in The Best Lawyers in America, Health Care Law, Woodward/White, Inc., 2021-2023
Recognized in "Readers' Choice Awards", Named #1 M&A Author, JD Supra, 2022
Selected for inclusion as a "Leading Lawyer" in Healthcare, Chambers USA, 2018-2022
Selected, "Women, Influence & Power in Law Award: Thought Leadership," Corporate Counsel, 2021
Selected for inclusion in “Legal 500 United States,” Healthcare: Advice to Service Providers, 2021
Recognized in "2021 Midwest Trailblazers," The American Lawyer, 2021
Recognized in "Readers' Choice Awards", Top Author in Healthcare and M&A, JD Supra, 2019, 2020
Named a "Healthcare Law Trailblazer," The National Law Journal, 2019
Selected for inclusion as a "Leading Lawyer," Healthcare: Service Providers, Legal 500 US, 2016-2018
Named one of "The 2017 Most Influential Women in Mid-Market M&A," Mergers & Acquisitions magazine, 2017
Named to "Illinois Rising Stars," Healthcare, Super Lawyers, Thomson Reuters, 2011
Sabrina A. Beldner Named L&E Lawyer of the Year in Euromoney’s Women in Business Law Awards
June 13, 2022
Five McGuireWoods Partners Named Finalists for Euromoney’s Women in Business Law Awards
May 3, 2022
McGuireWoods and McGuireWoods Consulting Honored in JD Supra’s Readers’ Choice Awards
March 7, 2022
The New York Times Quotes Amber Walsh on Delayed Care for Non-COVID Patients
September 27, 2021